Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cyperus amuricus extract is an herbal preparation derived from the whole plant of Cyperus amuricus, a perennial sedge used in oriental folk medicine for its purported astringent, diuretic, wound healing, and intestinal-protective effects. In preclinical studies, particularly using methanol extracts, it has demonstrated inhibitory effects on the proliferation of human hepatocellular carcinoma (Hep3B) cells by inducing cell cycle arrest and promoting apoptosis through modulation of cell cycle regulators and activation of caspases, with effects mediated via mitochondrial membrane permeability, cytochrome c release, and regulation of pro- and anti-apoptotic proteins. The extract has also shown traditional use in the treatment of wounds, tumors, and gastrointestinal complaints, and exhibits antioxidant and pancreatic lipase-inhibitory activity in vitro. However, there is no established clinical trial evidence or regulatory approval for pharmaceutical use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cyperus amuricus extract.